|

Functional and Quality of Life Improvement Following Transcatheter Heart Valve Implantation

RECRUITINGSponsored by Sheba Medical Center
Actively Recruiting
SponsorSheba Medical Center
Started2013-11
Est. completion2030-11
Eligibility
Age18 Years – 110 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT02023060

Summary

The objective is to observe trends in patient characteristics and outcomes after aortic or mitral transcatheter heart valve replacement over time.

Eligibility

Age: 18 Years – 110 YearsHealthy volunteers accepted
Inclusion Criteria:

1. Subject selected for transcatheter heart valve replacement
2. Signed informed consent to participate in the study

Exclusion Criteria:

1. Inability to sign written informed consent.
2. Pregnancy or breast feeding (women of childbearing potential will have a serum or urine pregnancy test).

Conditions3

Aortic StenosisHeart DiseaseTrans Catheter Aortic Valve

Browse More Trials

Heart Disease trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.